The present invention relates to the use of agomelatine, or N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide, in obtaining medicaments intended for the treatment of periventricular leukomalacia.

 
Web www.patentalert.com

< Treatment and prevention of cardiovascular disease in patients with chronic kidney disease by administering Omega-3 Fatty Acids

> Modified Human Plasma Polypeptide or Fc Scaffolds and Their Uses
~ 00437